BioCryst Pharmaceuticals
BCRX
#4535
Rank
A$2.87 B
Marketcap
$13.89
Share price
1.39%
Change (1 day)
64.60%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2023 (TTM): -$1.88

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.99. In 2022 the company made an earnings per share (EPS) of -$2.12 a decrease over its 2021 EPS that were of -$1.64.

EPS history for BioCryst Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.88-11.38%
2022-$2.1229.13%
2021-$1.64-4.63%
2020-$1.7210.2%
2019-$1.560%
2018-$1.5625.64%
2017-$1.244%
2016-$1.1927.12%
2015-$0.94-13.24%
2014-$1.0823.64%
2013-$0.88-30.38%
2012-$1.26-37.3%
2011-$2.0065.79%
2010-$1.21117.14%
2009-$0.56-46.15%
2008-$1.03-26.97%
2007-$1.42-40.67%
2006-$2.3948.51%
2005-$1.611%
2004-$1.5938.89%
2003-$1.15-25%
2002-$1.53231.03%
2001-$0.46-56.72%
2000-$1.0791.43%
1999-$0.562.94%
1998-$0.54-55.84%
1997-$1.2311.59%
1996-$1.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.33-267.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-$12.46 526.40%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.94-52.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-$11.44 475.20%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.98-451.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.82 92.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.57-380.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$19.22 866.40%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.23-38.40%๐Ÿ‡บ๐Ÿ‡ธ USA